Genetic Technologies Limited (NASDAQ:GENE) is a $9.9 million organization. That pales – considerably – in comparison to $1.15 billion Genomic Health, and is downright dwarfed by $2.8 billion Myriad Genetics. That small size alone is alarming to newcomers – never even mind the fact that GENE shares have fallen 73% over the past twelve months. As they say, though, nothing lasts forever, and it looks like that weakness has run its course and Genetic Technologies Limited has already begun to recover. Genetic Technologies Limited (NASDAQ:GENE) belongs to Healthcare sector. Its weekly performance is -0.02%. On last trading day company shares ended up $0.45. Genetic Technologies Limited (NASDAQ:GENE) distance from 50-day simple moving average (SMA50) is -15.86%.

Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, today announced that the Company will release its third-quarter 2014 financial results before market open on Thursday, November 6, 2014. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) shares decreased -2.39% in last trading session and ended the day at $8.59. DRNA return on assets is -36.70%. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) quarterly performance is -40.14%.

Sovran Self Storage (NYSE:SSS) last released its earnings data on Wednesday, October 29th. The company reported $1.17 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.13 by $0.04. The company had revenue of $85.20 million for the quarter, compared to the consensus estimate of $84.60 million. During the same quarter in the prior year, the company posted $1.01 earnings per share. The company’s quarterly revenue was up 20.9% on a year-over-year basis. Analysts expect that Sovran Self Storage will post $4.16 EPS for the current fiscal year. On 05 November, Sovran Self Storage Inc. (NYSE:SSS) shares moved up 0.21% and was closed at $85.62. SSS EPS growth in last 5 year was 7.80%. Sovran Self Storage Inc. (NYSE:SSS) year to date (YTD) performance is 36.36%.

Evercore Partners (NYSE:EVR) CEO Andrew Sibbald sold 13,899 shares of the stock in a transaction that occurred on Tuesday, October 28th. The shares were sold at an average price of $50.36, for a total transaction of $699,953.64. Following the completion of the sale, the chief executive officer now directly owns 252,563 shares of the company’s stock, valued at approximately $12,719,073. Evercore Partners Inc. (NYSE:EVR) ended the last trading day at $50.80. Company weekly volatility is calculated as 2.54% and price to cash ratio as 6.81. Evercore Partners Inc. (NYSE:EVR) showed a weekly performance of 0.04%.

MagnaChip Semiconductor Corporation (“MagnaChip” or the “Company”) (NYSE: MX), a Korea-based designer and manufacturer of analog and mixed-signal semiconductor products, on 07 October 2014 announced that it has received an extension for continued listing and trading of the Company’s common stock on the New York Stock Exchange ( the “NYSE”). MagnaChip Semiconductor Corporation (NYSE:MX) shares decreased -1.87% in last trading session and ended the day at $11.04. MagnaChip Semiconductor Corporation (NYSE:MX) quarterly performance is -19.42%.